Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kimberly M. Hamann"'
Autor:
Sumati Gupta, Theodore Stewart Gourdin, Aaron Hardin, Petros Grivas, Lesli A. Kiedrowski, Roby Antony Thomas, Nicholas J. Vogelzang, Guru Sonpavde, Kimberly M. Hamann, Bishoy Faltas
Publikováno v:
Bladder Cancer. 7:143-148
Detecting genomic alterations (GAs) in advanced urothelial carcinoma (aUC) can expand treatment options by identifying candidates for targeted therapies. Erdafitinib is FDA-approved for patients with platinum-refractory aUC with activating mutation o
Autor:
Alshad S. Lalani, Feng Gao, Rachel A. Freedman, Mark D. Pegram, Shana Thomas, Gretchen Kimmick, Matthew Bidwell Goetz, Julie R. Nangia, Ron Bose, Lisa A. Carey, Matthew J. Ellis, Melody A. Cobleigh, Jill Anderson, Timothy J. Pluard, Brittney Haas, Kimberly M. Hamann, Janice Lu, Jason Jones, Richard A. Bryce, Jingqin Luo, P. Kelly Marcom, Cynthia X. Ma, Frances Valdez-Albini, Nan Lin, Eric P. Winer
Publikováno v:
Cancer Research. 81:CT026-CT026
Introduction: The irreversible pan-HER inhibitor NER showed modest single agent activity for HER2mut MBC in Part I of MutHER trial. In Part II, we hypothesized that (1) N+F would improve activity in estrogen receptor positive (ER+) HER2mut MBC due to